Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ER Niacin on Immune Activation in HIV
NCT02018965Phase 2Completed
- Sponsor
- McGill University Health Centre
- Start
- Nov 2011
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of niacin in human immunodeficiency virus infection (HIV), sponsored by McGill University Health Centre. Started Nov 2011; status: completed.
02
Drugs
niacin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02018965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02018965.